Effect of Unani Medicine in Intellectual Deficit in Stroke Patients

Phase 2

• Conditions: Health Condition 1: F70-F79- Intellectual disabilities

• Registration Number: CTRI/2024/06/068413
• Lead Sponsor: ational Institute of Unani Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 24 June 2024

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1)Age ranges from 30 to 75 years (30 and 75 also included), no gender limitation.

2)The presence of cognitive impairments (Montreal Cognitive Assessment, MoCA less than 26).

3)Patients having single ischaemic or haemorrhagic stroke documented by cerebral CT scanning or MRI before enrolment.

4)Patients having history of stroke more than 6 weeks.

5)No severe aphasia and able to accomplish cognitive tests.

6)Stable vitals, no progression of neurological symptoms.

7) Normal cognitive function before stroke.

8)Voluntary participation and signing the informed consent.

9)Educational level should be primary school or above, with the capability of finishing cognitive tests.

Exclusion Criteria

1)Patients with pre stroke cognitive impairment.

2)Any neuropsychiatric comorbidity and affective disorder that could influence the test outcomes.

3)Patients with uncorrectable visual or hearing disturbances severe enough to preclude cognitive tests.

4)History of transcranial surgery or skull defect

5)Previous history of more than one episode of stroke.

6)Severe Aphasia.

7)Chronic Alcoholism.

8)Uncontrolled hypertension and Diabetes mellitus.

9)A medical condition that, in the investigator opinion, would interfere with treatment, safety, or adherence to the protocol.

Study & Design

• Study Type: Interventional
• Study Design: Not specified